The HCPLive Psychiatry condition center page is a comprehensive resource for clinical news and insights on mental illnesses. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for depression, schizophrenia, bipolar disorder, anxiety, and more.
October 3rd 2024
A study reveals that individuals with schizophrenia spectrum disorders experience high rates of comorbid mental health conditions and receive minimally adequate treatment.
September 26th 2024
September 20th 2024
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Alzheimer's Agitation Eased by Citalopram, But With Severe Adverse Effects
In a recent clinical trial, Celexa (citalopram) reduced agitation in patients with probable Alzheimer's disease (AD) compared to placebo, but the drug also produced severe cognitive and cardiac adverse events that prescribers must consider.
Late-Onset Alzheimer's Disease in Both Parents May Boost Dementia Risk in Adult Offspring
Patients who are free of dementia but have 2 parents with late-onset Alzheimer's disease may show signs of the disease in brain scans several years, if not decades, before they display clinical symptoms.
Heart Disease Linked to Cognitive Decline in Elderly Postmenopaual Women
A recent study published online in the Journal of the American Heart Association discovered an association between cardiovascular disease (CVD) and cognitive decline in postmenopausal women between the ages of 65 and 79 years old.
Dramatic Weight Loss from Bariatric Surgery Can Alter Identity
January 7th 2014While numerous patients require psychiatric interventions before and immediately after surgery, a new report addresses a different psychological process that can occur months or even years later: major quality-of-life (QOL) perception changes related to dramatic weight loss.
What Should I Prescribe for This Man's Depression?
January 1st 2014Several factors should be considered when choosing a medication and dosing schedule for this depressed adult male who reports being "very sensitive" to medication and expresses particular concern about being either sedated or "revved up" from an antidepressant.
Brintellix Tackles Cognitive Dysfunction Related to Major Depression
In addition to treating episodes of major depression, Brintellix (vortioxentine) has demonstrated superiority to placebo on measures of cognitive function in adult patients with major depressive disorder (MDD).
Smoking Cessation Therapy Does Not Interfere with Simultaneous Stimulant Addiction Treatment
A study published in The Journal of Clinical Psychiatry concludes that adults dependent on cocaine and/or methamphetamine who undergo stimulant addiction treatment does not detract from simultaneous smoking cessation therapy, and can even increase likelihood of quitting.
Increasing NMDA Glutamate Receptor Instead of Blocking It Produces Antidepressant-Like Effects
Results from animal models of depression and a human clinical trial show that enhancing, instead of blocking, the NMDA glutamate receptor can cause antidepressant-like effects.
Within a year of their diagnosis, nearly half of all first-line drug-treated MDD patients were also treated with a second-line therapy, a new study finds. Cymbalta leads the market in second-line therapy, used individually or as a combination, and Abilify is the leading atypical antipsychotic.